NCT00450762View on ClinicalTrials.gov

Gemcitabine + Carboplatin in Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2004

Study Completion Date

October 31, 2006

Conditions

Breast Cancer

Interventions

DRUG

gemcitabine

DRUG

carboplatin

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00450762 - Gemcitabine + Carboplatin in Breast Cancer | Biotech Hunter | Biotech Hunter